glaucomaНациональный журнал ГлаукомаNational Journal glaucoma2078-41042311-6862Federal State Budgetary Institution of Science “Krasnov Research Institute of Eye Diseases”10.25700/NJG.2020.01.07glaucoma-274Research ArticleОБЗОР ЛИТЕРАТУРЫREVIEW OF LITERATUREСелективная лазерная трабекулопластика как стартовый метод лечения первичной открытоугольной глаукомыSelective laser trabeculoplasty as the initial treatment of primary open-angle glaucomaЕричевВ. П.ErichevV. P.

Еричев Валерий Петрович, д.м.н., профессор, руководитель отдела глаукомы

Med.Sc.D., Professor, Head of Glaucoma Department

erichev@reic.ruРагозинаЕ. А.RagozinaE. A.

ординатор

resident

ФГБНУ «НИИ глазных болезней»РоссияScientific Research Institute of Eye DiseasesRussian Federation2020200420201914754Copyright © Еричев В.П., Рагозина Е.А., 20202020Еричев В.П., Рагозина Е.А.Erichev V.P., Ragozina E.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.glaucomajournal.ru/jour/article/view/274

Селективная лазерная трабекулопластика (СЛТ) является сравнительно молодым методом снижения внутриглазного давления у больных первичной открытоугольной глаукомой (ПОУГ). К основным преимуществам СЛТ относят ее безопасность и эффективность. Во всем мире лазерные методы являются второй линией лечения глаукомы, которое в большинстве случаев начинают с подбора местных гипотензивных средств. Известно, что активные компоненты глазных капель и содержащиеся в них консерванты вызывают нежелательные побочные эффекты. Данная проблема особенно актуальна у пациентов с глаукомой из-за необходимости в пожизненной терапии с момента постановки диагноза. Кроме того, механизмы взаимодействия антиглаукомных препаратов и лекарств, принимаемых пациентами по поводу общих заболеваний, остаются не до конца изученными. В связи с вышеуказанными проблемами вопрос о возможности проведения СЛТ пациентам с впервые выявленной ПОУГ на сегодняшний день остается актуальным. В нашем обзоре мы сравнили методы селективной лазерной трабекулопластики и медикаментозной терапии, анализируя имеющуюся информацию относительно показаний, противопоказаний, осложнений, эффективности методов, качества жизни пациентов и экономических аспектов

Selective laser trabeculoplasty (SLT) is a relatively new method of intraocular pressure lowering in patients with primary open-angle glaucoma (POAG). The main advantages of SLT are its safety and effectiveness. Laser methods are considered to be the second line of glaucoma treatment worldwide. Hyportensive drugs are usually used as the initial method for glaucoma patients. It is common knowledge that preservatives and active components of eye drops usually cause adverse effects. This problem is especially relevant in patients with POAG due to the need for lifelong therapy starting from the moment of proving the diagnosis. In addition, the mechanisms of interaction between antiglaucoma drugs and medications for extraocular diseases remain unclear. Therefore, the question of initial SLT in patients with newly diagnosed POAG remains essentially important. In our review we compared the methods of selective laser trabeculoplasty and drug therapy in glaucoma treatment, analyzing available information regarding indications, contraindications, complications and effectiveness of the methods, patients’ quality of life and economic aspects.

первичная открытоугольная глаукомаселективная лазерная трабекулопластикагипотензивная эффективностьвнутриглазное давлениеprimary open-angle glaucomaselective laser trabeculoplastyhypotensive efficacyintraocular pressureReferencesQuigley H.A. Clinical trials for glaucoma neuroprotection are not impossible. Curr Opin Ophthalmol. 2012; 23(2):144–154. doi: 10. 1097/ICU.0b013e32834ff490Quigley H.A. Clinical trials for glaucoma neuroprotection are not impossible. Curr Opin Ophthalmol. 2012; 23(2):144–154. doi: 10. 1097/ICU.0b013e32834ff490Большунов А.В. Вопросы лазерной офтальмологии. М.: Апрель; 2013. 316 с.Bolshunov A.V. Voprosy lazernoj oftal'mologii [The Issues of laser of ophthalmology]. Moscow: April; 2013. 316 p.European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options. Br J Ophthalmol. 2017; 101:130-195.European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options. Br J Ophthalmol. 2017; 101:130-195.Guglielmi P., Carradori S., Campestre C., Poce G. Novel therapies for glaucoma: a patent review (2013-2019), Exper Opin Therapeutic Patents. 2019; 29(10):769-780. doi: 10.1080/13543776.2019.1653279Guglielmi P., Carradori S., Campestre C., Poce G. Novel therapies for glaucoma: a patent review (2013-2019), Exper Opin Therapeutic Patents. 2019; 29(10):769-780. doi: 10.1080/13543776.2019.1653279Anderson R.R., Parrish J.A. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983; 220:524–527. doi: 10.1126/science.6836297Anderson R.R., Parrish J.A. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983; 220:524–527. doi: 10.1126/science.6836297Latina M.A., Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res. 1995; 60:359-371. doi: 10.1016/s0014-4835(05)80093-4Latina M.A., Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res. 1995; 60:359-371. doi: 10.1016/s0014-4835(05)80093-4Kagan D.B., Gorfinkel N.S., Hutnik C.M. Mechanisms of selective laser trabeculoplasty: a review. Clin Exp Ophthalmol. 2014; 42:675-681. doi: 10.1111/ceo.12281Kagan D.B., Gorfinkel N.S., Hutnik C.M. Mechanisms of selective laser trabeculoplasty: a review. Clin Exp Ophthalmol. 2014; 42:675-681. doi: 10.1111/ceo.12281Garg A., Gazzard G. Selective laser trabeculoplasty: past, present, and future. Eye. 2018; 32:863-876. doi: 10.1038/eye.2017.273Garg A., Gazzard G. Selective laser trabeculoplasty: past, present, and future. Eye. 2018; 32:863-876. doi: 10.1038/eye.2017.273Kramer T.R., Noecker R.J. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology. 2001; 108:773–779. doi: 10.1016/s0161-6420(00)00660-6Kramer T.R., Noecker R.J. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology. 2001; 108:773–779. doi: 10.1016/s0161-6420(00)00660-6Cvenkel B., Hvala A., Drnovsek-Olup B., Gale N. Acute ultrastructural changes of the trabecular meshwork after selective laser trabeculoplasty and low power argon laser trabeculoplasty. Lasers Surg Med. 2003; 33:204–208. doi: 10.1002/lsm.10203Cvenkel B., Hvala A., Drnovsek-Olup B., Gale N. Acute ultrastructural changes of the trabecular meshwork after selective laser trabeculoplasty and low power argon laser trabeculoplasty. Lasers Surg Med. 2003; 33:204–208. doi: 10.1002/lsm.10203SooHoo J.R., Seibold L.K., Ammar D.A., Kahook M.Y. Ultrastructural changes in human trabecular meshwork tissue after laser trabeculoplasty. J Ophthalmol. 2015; 2015:476138. doi: 10.1155/2015/476138SooHoo J.R., Seibold L.K., Ammar D.A., Kahook M.Y. Ultrastructural changes in human trabecular meshwork tissue after laser trabeculoplasty. J Ophthalmol. 2015; 2015:476138. doi: 10.1155/2015/476138Alvarado J.A., Iguchi R., Martinez J., Trivedi S., Similar effects of selective laser trabeculoplasty and prostaglandin analogs on the permeability of cultured Schlemm canal cells. Am J Ophthalmol. 2010; 150:254–264. doi: 10.1016/j.ajo.2010.03.012Alvarado J.A., Iguchi R., Martinez J., Trivedi S., Similar effects of selective laser trabeculoplasty and prostaglandin analogs on the permeability of cultured Schlemm canal cells. Am J Ophthalmol. 2010; 150:254–264. doi: 10.1016/j.ajo.2010.03.012Hirabayashi M.T., Rosenlof T.L., An J.A. Comparison of successful outcome predictors for MicroPulse® laser trabeculoplasty and selective laser trabeculoplasty at 6 months. Clin Ophthalmol. 2019; 13:1001– 1009. doi: 10.2147/OPTH.S205977Hirabayashi M.T., Rosenlof T.L., An J.A. Comparison of successful outcome predictors for MicroPulse® laser trabeculoplasty and selective laser trabeculoplasty at 6 months. Clin Ophthalmol. 2019; 13:1001– 1009. doi: 10.2147/OPTH.S205977Ayala M., Enping C. Predictive factors of success in selective laser trabeculoplasty (SLT) treatment. Clin Ophthalmol. 2011; 5:573–576. doi: 10.2147/OPTH.S19873Ayala M., Enping C. Predictive factors of success in selective laser trabeculoplasty (SLT) treatment. Clin Ophthalmol. 2011; 5:573–576. doi: 10.2147/OPTH.S19873Hodge W.G., Damji K.F., Rock W., Buhrmann R. Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial. Br J Ophthalmol. 2005; 89(9):1157– 1160. doi: 10.1136/bjo.2004.062414Hodge W.G., Damji K.F., Rock W., Buhrmann R. Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial. Br J Ophthalmol. 2005; 89(9):1157– 1160. doi: 10.1136/bjo.2004.062414Shazly T.A., Latina M.A., Dagianis J.J., Chitturi S. Effect of prior cataract surgery on the long-term outcome of selective laser trabeculoplasty. Clin Ophthalmol. 2011; 5:377-80. doi: 10.2147/OPTH.S17237Shazly T.A., Latina M.A., Dagianis J.J., Chitturi S. Effect of prior cataract surgery on the long-term outcome of selective laser trabeculoplasty. Clin Ophthalmol. 2011; 5:377-80. doi: 10.2147/OPTH.S17237Lee J.W., Wong M.O., Wong R.L., Lai J.S. Correlation of intraocular pressure between both eyes after bilateral selective laser trabeculoplasty in open-angle glaucoma. J Glaucoma. 2016; 25(3):248–252. doi: 10.1097/IJG.0000000000000274Lee J.W., Wong M.O., Wong R.L., Lai J.S. Correlation of intraocular pressure between both eyes after bilateral selective laser trabeculoplasty in open-angle glaucoma. J Glaucoma. 2016; 25(3):248–252. doi: 10.1097/IJG.0000000000000274Shazly T.A., Latina M.A. Intraocular pressure response to selective laser trabeculoplasty in the first treated eye vs the fellow eye. Arch Ophthalmol. 2011; 129(6):699-702. doi: 10.1001/archophthalmol.2011.108Shazly T.A., Latina M.A. Intraocular pressure response to selective laser trabeculoplasty in the first treated eye vs the fellow eye. Arch Ophthalmol. 2011; 129(6):699-702. doi: 10.1001/archophthalmol.2011.108Shazly T.A., Latina M.A., Dagianis J.J., Chitturi S. Effect of central corneal thickness on the long-term outcome of selective laser trabeculoplasty as primary treatment for ocular hypertension. Cornea. 2012; 31:883–886. doi: 10.1097/ICO.0b013e318243f684Shazly T.A., Latina M.A., Dagianis J.J., Chitturi S. Effect of central corneal thickness on the long-term outcome of selective laser trabeculoplasty as primary treatment for ocular hypertension. Cornea. 2012; 31:883–886. doi: 10.1097/ICO.0b013e318243f684Hirneiss C., Sekura K., Brandlhuber U., Kampik A. Corneal biomechanics predict the outcome of selective laser trabeculoplasty in medically uncontrolled glaucoma. Graefes Arch Clin Exp Ophthalmol. 2013; 251:2383–2388. doi: 10.1007/s00417-013-2416-2Hirneiss C., Sekura K., Brandlhuber U., Kampik A. Corneal biomechanics predict the outcome of selective laser trabeculoplasty in medically uncontrolled glaucoma. Graefes Arch Clin Exp Ophthalmol. 2013; 251:2383–2388. doi: 10.1007/s00417-013-2416-2Martow E., Hutnik C.M., Mao A. SLT and adjunctive medical therapy: a prediction rule analysis. J Glaucoma. 2011; 20:266–270. doi: 10.1097/IJG.0b013e3181e3d2c1Martow E., Hutnik C.M., Mao A. SLT and adjunctive medical therapy: a prediction rule analysis. J Glaucoma. 2011; 20:266–270. doi: 10.1097/IJG.0b013e3181e3d2c1Woo D.M., Healey P.R., Graham S.L., Goldberg I. Intraocular pressurelowering medications and long-term outcomes of selective laser trabeculoplasty. Clin Exp Ophthalmol. 2015; 43:320-327. doi: 10.1111/ ceo.12452Woo D.M., Healey P.R., Graham S.L., Goldberg I. Intraocular pressurelowering medications and long-term outcomes of selective laser trabeculoplasty. Clin Exp Ophthalmol. 2015; 43:320-327. doi: 10.1111/ ceo.12452Lee J.W., Liu C.C., Chan J., Wong R.L., Predictors of success in selective laser trabeculoplasty for primary open angle glaucoma in Chinese. Clin Ophthalmol. 2014; 8:1787–1791. doi: 10.2147/OPTH. S69166Lee J.W., Liu C.C., Chan J., Wong R.L., Predictors of success in selective laser trabeculoplasty for primary open angle glaucoma in Chinese. Clin Ophthalmol. 2014; 8:1787–1791. doi: 10.2147/OPTH. S69166Bruen R., Lesk M.R., Harasymowycz P. Baseline factors predictive of SLT response: a prospective study. J Ophthalmol. 2012; 2012: 642869. doi: 10.1155/2012/642869Bruen R., Lesk M.R., Harasymowycz P. Baseline factors predictive of SLT response: a prospective study. J Ophthalmol. 2012; 2012: 642869. doi: 10.1155/2012/642869Pillunat K.R., Spoerl E., Elfes G., Pillunat L.E. Preoperative intraocular pressure as a predictor of selective laser trabeculoplasty efficacy. Acta Ophthalmol. 2016; 94:692–696. doi: 10.1111/aos.13790Pillunat K.R., Spoerl E., Elfes G., Pillunat L.E. Preoperative intraocular pressure as a predictor of selective laser trabeculoplasty efficacy. Acta Ophthalmol. 2016; 94:692–696. doi: 10.1111/aos.13790Lee J.W., Ho W.L, Chan J.C., Lai J.S. Efficacy of selective laser trabeculoplasty for normal tension glaucoma: 1 year results. BMC Ophthalmol. 2015; 15:1. doi: 10.1186/1471-2415-15-1Lee J.W., Ho W.L, Chan J.C., Lai J.S. Efficacy of selective laser trabeculoplasty for normal tension glaucoma: 1 year results. BMC Ophthalmol. 2015; 15:1. doi: 10.1186/1471-2415-15-1Lee J.W., Shum J.J., Chan J.C., Lai J.S. Two-year clinical results after selective laser trabeculoplasty for normal tension glaucoma. Medicine (Baltimore). 2015; 94(24):984. doi: 10.1097/MD.0000000000000984Lee J.W., Shum J.J., Chan J.C., Lai J.S. Two-year clinical results after selective laser trabeculoplasty for normal tension glaucoma. Medicine (Baltimore). 2015; 94(24):984. doi: 10.1097/MD.0000000000000984Alon S. Selective laser trabeculoplasty: a clinical review. J Curr Glaucoma Pract. 2013; 7(2):58–65. doi: 10.5005/jp-journals-10008-1139Alon S. Selective laser trabeculoplasty: a clinical review. J Curr Glaucoma Pract. 2013; 7(2):58–65. doi: 10.5005/jp-journals-10008-1139Глаукома. Национальное руководство. Под ред. Е.А. Егорова. М.: ГЕОТАР-Медиа; 2013. 824 с.Egorov E.A. Glaukoma. Natsional'noe rukovodstvo. [Glaucoma. National Guideline]. Moscow: GEOTAR-Media; 2013. 824 p. (In Russ.).Еричев В.П., Макарова А.С. Совместимость системных препаратов и местной гипотензивной терапии у пациентов с первичной открытоугольной глаукомой (аналитический обзор). Офтальмология. 2018; 15(4):366-373. doi: 10.18008/1816-5095-2018-4-366-373Erichev V.P., Makarova A.S. Compatibility of systemic drugs and local antihypertensive therapy in patients with primary open-angle glaucoma (analytical review). Ophthalmology in Russia. 2018; 15(4):366- 373. (In Russ.). doi: 10.18008/1816-5095-2018-4-366-373Ang M., Tham C.C., Sng C.C.A. Selective laser trabeculoplasty as the primary treatment for open-angle glaucoma: time for change? Eye. 2019. doi: 10.1038/s41433-019-0625-6Ang M., Tham C.C., Sng C.C.A. Selective laser trabeculoplasty as the primary treatment for open-angle glaucoma: time for change? Eye. 2019. doi: 10.1038/s41433-019-0625-6Lai J.S., Chua J.K., Tham C.C., Lam D.S. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clin Exper Ophthalmol. 2004; 32:368–372. doi: 10.1111/j.1442-9071.2004.00839.xLai J.S., Chua J.K., Tham C.C., Lam D.S. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clin Exper Ophthalmol. 2004; 32:368–372. doi: 10.1111/j.1442-9071.2004.00839.xNagar M., Luhishi E., Shah N. Intraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplasty. Br J Ophthalmol. 2009; 93:497–501. doi: 10.1136/bjo.2008Nagar M., Luhishi E., Shah N. Intraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplasty. Br J Ophthalmol. 2009; 93:497–501. doi: 10.1136/bjo.2008Li X., Wang W., Zhang X.. Meta-analysis of selective laser trabeculoplasty versus topical medication in the treatment of open-angle glaucoma. BMC Ophthalmol. 2015; 5:107. doi: 10.1186/s12886-015-0091-2Li X., Wang W., Zhang X.. Meta-analysis of selective laser trabeculoplasty versus topical medication in the treatment of open-angle glaucoma. BMC Ophthalmol. 2015; 5:107. doi: 10.1186/s12886-015-0091-2Wong M.O., Lee J.W., Choy B.N., Chan J.C. et al. Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma. Surv Ophthalmol. 2015; 60:36–50. doi: 10.1016/j.survophthal.2014.06.006Wong M.O., Lee J.W., Choy B.N., Chan J.C. et al. Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma. Surv Ophthalmol. 2015; 60:36–50. doi: 10.1016/j.survophthal.2014.06.006De Keyser M., De Belder M., De Groot V. Randomized prospective study of the use of anti-inflammatory drops after selective laser trabeculoplasty. J Glaucoma. 2017; 26:22-29. doi: 10.1097/IJG.0000000000000522De Keyser M., De Belder M., De Groot V. Randomized prospective study of the use of anti-inflammatory drops after selective laser trabeculoplasty. J Glaucoma. 2017; 26:22-29. doi: 10.1097/IJG.0000000000000522Harasymowycz P.J., Papamatheakis D.G., Latina M., De Leon M. et al. Selective laser trabeculoplasty (SLT) complicated by intraocular pressure elevation in eyes with heavily pigmented trabecular meshworks. Am J Ophthalmol. 2005; 139:1110–1113. doi: 10.1016/j.ajo.2004.11.038Harasymowycz P.J., Papamatheakis D.G., Latina M., De Leon M. et al. Selective laser trabeculoplasty (SLT) complicated by intraocular pressure elevation in eyes with heavily pigmented trabecular meshworks. Am J Ophthalmol. 2005; 139:1110–1113. doi: 10.1016/j.ajo.2004.11.038Zhang L., Weizer J.S., Musch D.C. Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty. Cochrane Database Syst Rev. 2017; 2(2):CD010746. doi: 10.1002/14651858.CD010746.pub2Zhang L., Weizer J.S., Musch D.C. Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty. Cochrane Database Syst Rev. 2017; 2(2):CD010746. doi: 10.1002/14651858.CD010746.pub2Song J. Complications of selective laser trabeculoplasty: a review. Clin Ophthalmol. 2016; 10:137–143. doi: 10.2147/OPTH.S84996Song J. Complications of selective laser trabeculoplasty: a review. Clin Ophthalmol. 2016; 10:137–143. doi: 10.2147/OPTH.S84996Liyanage S.E., Kumaran N., De Alwis D. Macular burns resulting from the accidental use of selective laser trabeculoplasty mode during a laser capsulotomy. Br J Ophthalmol. 2014; 98:141–142. doi: 10.1136/ bjophthalmol-2013-303489Liyanage S.E., Kumaran N., De Alwis D. Macular burns resulting from the accidental use of selective laser trabeculoplasty mode during a laser capsulotomy. Br J Ophthalmol. 2014; 98:141–142. doi: 10.1136/ bjophthalmol-2013-303489Lee J.W., Chan J.C., Chang R.T., Singh K. et al. Corneal changes after a single session of selective laser trabeculoplasty for open-angle glaucoma. Eye. 2014; 28(1):47–52. doi:10.1038/eye.2013.23Lee J.W., Chan J.C., Chang R.T., Singh K. et al. Corneal changes after a single session of selective laser trabeculoplasty for open-angle glaucoma. Eye. 2014; 28(1):47–52. doi:10.1038/eye.2013.23Latina M.A., Tumbocon J.A. Selective laser trabeculoplasty: a new treatment option for open angle glaucoma. Curr Opin Ophthalmol. 2002; 13(2):94–96. doi: 10.1097/00055735-200204000-00007Latina M.A., Tumbocon J.A. Selective laser trabeculoplasty: a new treatment option for open angle glaucoma. Curr Opin Ophthalmol. 2002; 13(2):94–96. doi: 10.1097/00055735-200204000-00007Knickelbein J.E., Singh A., Flowers B.E., Unni K.N. et al. Acute corneal edema with subsequent thinning and hyperopic shift following selective laser trabeculoplasty. J Cataract Refract Surg. 2014; 40(10):1731– 1735. doi: 10.1016/j.jcrs.2014.08.002Knickelbein J.E., Singh A., Flowers B.E., Unni K.N. et al. Acute corneal edema with subsequent thinning and hyperopic shift following selective laser trabeculoplasty. J Cataract Refract Surg. 2014; 40(10):1731– 1735. doi: 10.1016/j.jcrs.2014.08.002Wolfram C., Stahlberg E., Pfeiffer N. Patient-reported nonadherence with glaucoma therapy. J Ocul Pharmacol Ther. 2019; 35(4):223–228. doi: 10.1089/jop.2018.0134Wolfram C., Stahlberg E., Pfeiffer N. Patient-reported nonadherence with glaucoma therapy. J Ocul Pharmacol Ther. 2019; 35(4):223–228. doi: 10.1089/jop.2018.0134Gazzard G., Konstantakopoulou E., Garway-Heath D., Garg A. et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet. 2019; 393(10180):1505-1516. doi: 10.1016/S0140-6736(18)32213-XGazzard G., Konstantakopoulou E., Garway-Heath D., Garg A. et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet. 2019; 393(10180):1505-1516. doi: 10.1016/S0140-6736(18)32213-XDe Keyser M., De Belder M., De Groot V. Quality of life in glaucoma patients after selective laser trabeculoplasty. Int J Ophthalmol. 2017; 10:742–748. doi: 10.18240/ijo.2017.05.14De Keyser M., De Belder M., De Groot V. Quality of life in glaucoma patients after selective laser trabeculoplasty. Int J Ophthalmol. 2017; 10:742–748. doi: 10.18240/ijo.2017.05.14Gazzard G., Konstantakopoulou E., Garway-Heath D., Barton K. et al. Laser in glaucoma and ocular hypertension (light) trial. A multicentre, randomised controlled trial: design and methodology. Br J Ophthalmol. 2018; 102:593–598. doi: 10.1136/bjophthalmol-2017-310877Gazzard G., Konstantakopoulou E., Garway-Heath D., Barton K. et al. Laser in glaucoma and ocular hypertension (light) trial. A multicentre, randomised controlled trial: design and methodology. Br J Ophthalmol. 2018; 102:593–598. doi: 10.1136/bjophthalmol-2017-310877Ang G.S., Fenwick E.K., Constantinou M., Gan A. et al. Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial. Br J Ophthalmol. 2019; Sep. 5:1–9. doi: 10.1136/bjophthalmol-2018-313396Ang G.S., Fenwick E.K., Constantinou M., Gan A. et al. Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial. Br J Ophthalmol. 2019; Sep. 5:1–9. doi: 10.1136/bjophthalmol-2018-313396Чупров А.Д., Канюков В.Н., Кадникова О.В., Екимов А.К. Экономическая эффективность селективной трабекулопластики. Национальный журнал глаукома. 2017; 16(3):36-42.Chuprov A.D., Kanyukov V.N., Kadnikova O.V., Ekimov A.K. Economic effectiveness of selective trabeculoplasty. Natsional'nyi zhurnal glaucoma. 2017; 16(3): 36-42. (In Russ.).

The authors declare that there are no conflicts of interest present.